NECTIN4 and neoplasm: Tumor uptake of EV-F(ab′)2 in the low nectin-4–expressing UM-UC-3 model was minimal (2.27 ± 0.45 %ID/g, P < 0.01) compared with HT-1376 and SW780, confirming nectin-4–specific targeting.